drugset / Trial / NCT05447507

Comparison of Remimazolam and Dexmedetomidine for Intraoperative Sedation

NCT05447507

Phase 4 Completed 104 enrolled Seoul National University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the sedation efficacy of dexmedetomidine and remimazolam for intraoperative sedation during regional block.

Timeline

Start
2022-07-08
Primary completion
2022-10-26
Completion
2022-10-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.2 ug/kg
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg
Comparator Remimazolam Small molecule 0.5 mg/kg
Comparator Remimazolam Small molecule 1 mg/kg